e8vk
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 23, 2008
Date of report (Date of earliest event reported)
SurModics, Inc.
(Exact Name of Registrant as Specified in its Charter)
         
Minnesota   0-23837   41-1356149
         
(State of Incorporation)   (Commission File Number)   (I.R.S. Employer
Identification No.)
         
9924 West 74th Street
   
Eden Prairie, Minnesota
  55344
     
(Address of Principal Executive Offices)
  (Zip Code)
         
(952) 829-2700
 
(Registrant’s Telephone Number, Including Area Code)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02. Results of Operations And Financial Condition.
Item 9.01. Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
Press Release


Table of Contents

Item 2.02. Results of Operations And Financial Condition.
     On January 23, 2008, SurModics, Inc. issued a press release announcing the results for the quarter ended December 31, 2007. A copy of the full text of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01. Financial Statements and Exhibits.
  (a)   Financial Statements: None.
 
  (b)   Pro forma financial information: None.
 
  (c)   Shell company transactions: None.
 
  (d)   Exhibits: 99.1 Press Release dated January 23, 2008.

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  SURMODICS, INC.
 
 
Date: January 23, 2008  /s/ Philip D. Ankeny    
  Philip D. Ankeny   
  Chief Financial Officer   

 


Table of Contents

         
EXHIBIT INDEX
         
Exhibit    
Number   Description
       
 
  99.1    
Press Release dated January 23, 2008.